4 trends in process development for the specialty chemicals industry

NICOLAAS VIETS | January 17, 2018

article image
The specialty chemicals industry operates within a unique space with exciting opportunities as well as an increasing number of challenges. Producing chemicals that meet functional performance is no longer enough. To remain competitive in the specialty chemicals space, producers need to drive or at least keep up with the trends in their industry. The specialty chemicals space is also highly sensitive to global events. A strong dollar, Brexit, and stagnant economic growth heavily impacted the health of the industry in 2016, and those are only examples.

Spotlight

Ocular Therapeutix, Inc.

Ocular Therapeutix, Inc. is a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary hydrogel-based formulation technology. Ocular Therapeutix’s lead product candidate, DEXTENZA™ (dexamethasone insert) 0.4 mg for intracanalicular use, has completed Phase 3 clinical development for the treatment of ocular pain and inflammation following ophthalmic surgery.

OTHER ARTICLES

Global polyolefins for the rest of 2021: supply to lengthen as demand muddle continues

Article | May 2, 2021

SOMEHOW, despite the still very serious container freight shortages that have limited imports, buying sentiment seems to have weakened in the European polyolefins market, according to my outstanding ICIS colleague, Linda Naylor.

Read More

5 Biggest Pesticide Companies Are Making Billions From 'Highly Hazardous' Chemicals, Investigation Finds

Article | February 20, 2020

The analysis shows that the world's top five pesticide makers are making billions, accounting for more than 36 percent of their income, from chemicals that are proven to hazards to humans and the environment and are contributing to the precipitous demise of bee populations, as Unearthed reported. The researchers found that the sale of these highly hazardous pesticides (HHPs), disproportionately occurred in poorer nations, which often have fewer regulations than industrialized nations, according to The Guardian. In India, for example, sales of HHPs were nearly 60 percent, while in the UK it was just 11 percent.

Read More

How Chemical Companies Benefit from the Experience Economy

Article | February 10, 2020

To feel or experience from a business engagement started with customer experience mainly in the consumer products business. Today it has extended to even knowledge industries like the chemical industry where experiencing or feeling can be leveraged to include all stake holders from customers primarily to employees to supply chain people & suppliers and all else. With digital technologies this has become easier than before. The benefits from promoting the ‘feel’ or ‘experience’ emotion could be multifarious for the chemical industry as described in this article.

Read More

Ensuring a Winning Strategy for Value Chain Optimization of the Refining and Petrochemical Industries

Article | March 24, 2020

The Refining and petrochemical industries have a projection to keep growing in the next two decades and companies that are investing in new technology today will be ahead of your competition in about 2 years. The digitalization of the value chain, also known as value chain optimization, is a complex task. Part of this complexity comes from the diversity of challenges that occurs in different areas of the value chain within each operation, as we addressed in the article Understanding the Refining and Petrochemical Value Chains to Drive Optimization. Many companies still fail to obtain economic return from their investment in digitalization and we presented the most common challenges in the article Challenges of Achieving Value Chain Optimization in the Refining and Petrochemical Industries. With so many challenges, how can businesses ensure they have a strategic digital transformation program that will successfully result in the optimization of your value chain?

Read More

Spotlight

Ocular Therapeutix, Inc.

Ocular Therapeutix, Inc. is a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary hydrogel-based formulation technology. Ocular Therapeutix’s lead product candidate, DEXTENZA™ (dexamethasone insert) 0.4 mg for intracanalicular use, has completed Phase 3 clinical development for the treatment of ocular pain and inflammation following ophthalmic surgery.

Events